PeptidePedia The community reference

Contributions of HedgeHedda

User contributions·18 logged edits·page 1 of 1

Contributions by HedgeHedda, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 222 edits includes activity predating the current log.

  1. 13:55, 19 Jun 2026 (diff | hist) Talk:Analytical method validation 885 +105 /* Uncharacterised is not wrong */ reply
  2. 10:30, 11 Jun 2026 (diff | hist) Talk:Sarcopenia 537 +169 /* Extrapolating the exercise evidence */ new section
  3. 13:50, 2 Jun 2026 (diff | hist) Talk:Growth hormone secretagogue 748 +106 /* Thin evidence base */ reply
  4. 10:38, 31 May 2026 (diff | hist) Haemoglobin A1c 4,243 ±0 clarify that the reference interval is not a treatment target
  5. 09:12, 25 Apr 2026 (diff | hist) Talk:Insulin secretion 959 +101 /* Beta-cell mass at diagnosis: the number keeps changing */ reply
  6. 14:05, 13 Apr 2026 (diff | hist) Talk:Adverse effects of GLP-1 receptor agonists 748 +96 /* Precautionary contraindication */ reply
  7. 10:50, 9 Apr 2026 (diff | hist) Talk:Gastric emptying 537 +156 /* Tachyphylaxis wording */ new section
  8. 13:15, 1 Apr 2026 (diff | hist) Talk:Aspiration risk under anaesthesia 611 +132 /* Caution proportionate to severity, not evidence */ reply
  9. 12:52, 30 Mar 2026 (diff | hist) Good manufacturing practice 5,123 ±0 state that a GMP claim is not a fact until assessed
  10. 13:20, 27 Feb 2026 (diff | hist) Talk:GLP-1 receptor 959 +124 /* Bias section overstates the therapeutic case */ reply
  11. 09:05, 27 Feb 2026 (diff | hist) Talk:GLP-1 receptor 537 +167 /* Bias section overstates the therapeutic case */ new section
  12. 13:25, 16 Jan 2026 (diff | hist) Talk:Melanotan II 611 +139 /* Melanoma case reports */ reply
  13. 16:40, 14 Oct 2025 (diff | hist) Talk:Semaglutide 1,022 +158 /* Rodent C-cell findings: how should the label contraindication be framed? */ reply
  14. 03:42, 17 Jul 2025 (diff | hist) Bacterial endotoxin test 5,088 ±0 m add the figure for the chromatogram and caption its axes
  15. 16:47, 26 Jun 2025 (diff | hist) Underfilling 3,863 ±0 ce, tighten prose
  16. 06:01, 5 Jun 2025 (diff | hist) Multi-dose vial 15,840 +225 m correct the unit conversion — U-100 not U-40
  17. 23:06, 19 Dec 2024 (diff | hist) Subcutaneous injection 3,730 ±0 m alphabetise the see-also list
  18. 04:28, 30 Nov 2024 (diff | hist) FLOW trial 2,601 ±0 add the number randomised and the number completing